What early HIPAA-ready moves reveal about enterprise healthcare AI

We are barely two weeks into the year, and healthcare AI has already crossed an important threshold.

Within days of each other, OpenAI and Anthropic released healthcare-focused announcements that move large language models out of experimentation and into HIPAA-aware, enterprise-ready territory. On the surface, the messaging sounds similar: HIPAA-ready AI, healthcare-grade security, and enterprise use cases. But just below that surface, the strategies diverge in ways that matter for health systems, RCM organizations, and healthcare technology leaders planning their 2026 roadmaps.
‍

CHATGPT AND CLAUDE SHARE A COMMON DEFINITION OF HIPAA-READY

HIPAA-ready does not mean “safe to paste PHI into any chat window”! At its core, HIPAA compliance in AI is not about the model. It is about the operating model around the model.

A HIPAA-ready AI offering requires the appropriate BAAs, Enterprise Agreements, data isolation and standard governance needed for roles, retention, and usage oversight.

In other words, AI itself does not become compliant, but we now have an available environment in which it can safely operate.  A governable industrial grade AI framework has finally arrived.

So, what will we do with this shiny new environment? From here the story radically shifts as Anthropic and OpenAI propose radically different solution paths and supporting ecosystems.  It can be a little bit overwhelming, so let's look at the big picture.
‍

A DIFFERENT WAY TO LOOK AT IT: FRONT-OF-HOUSE VS BACK-OFFICE GRAVITY CENTER

One helpful way to interpret the difference between these approaches is where each model naturally wants to live inside a healthcare organization. Their add-ons and announced acquisitions and integration partnerships tell the story.
‍
‍

CHATGPR: CONSUMER-FACING BY DESIGN, ECOSYSTEM-DRIVEN BY INTENT

ChatGPT’s healthcare strategy is not only clinician-adjacent, it's intentionally consumer-facing.

Beyond enterprise deployments, OpenAI is clearly investing in an ecosystem that supports patients actively bringing their own health data into the AI experience. Through a combination of recent acquisitions, enabling partnerships, and platform capabilities, ChatGPT is positioning itself as a trusted synthesis layer for consumer health information.

The direction is clear:

• Enable patients to share personal health data voluntarily
• Normalize AI as a place where individuals organize, interpret, and understand that data
• Deliver personalized insights that span conditions, history, and context rather than isolated data points

This is a meaningful strategic choice.

Rather than treating consumer health interaction as an edge case, ChatGPT appears to be embracing it as a core adoption vector; one that builds familiarity, trust, and daily usage long before a patient ever enters a clinical setting.

In that model, AI becomes:

• A personal health interpreter and coach
• A continuity layer across providers, encounters, and records
• A bridge between consumer understanding and clinical conversation

This reinforces why ChatGPT feels naturally suited to front-of-house healthcare experiences. Its strength is not just language, but synthesis—connecting disparate inputs into coherent, human-readable insight. When paired with governance and HIPAA-aware enterprise controls, that same capability scales into clinician workflows without losing its consumer roots.

The bet here is subtle but powerful:

If patients already trust an AI to understand their health, will clinicians and systems benefit from meeting them in that same shared context?

OpenAI is building the field of dreams with the understanding: If we build it, you will come. ChatGPT promotes a new business model for healthcare that doesn’t yet exist. An opportunity to enable and unlock informed consumer choice.
‍

CLAUDE: AGENTIC, WORKFLOW-FIRST, AND BACK-OFFICE ORIENTED

Claude’s healthcare positioning pulls in a different direction.

Rather than emphasizing a generalized enterprise assistant, Claude is framed around agentic, workflow-oriented automation, with specific healthcare use cases surfaced out of the box. Prior authorization support, coverage determination, benefits validation, and similar administrative workflows are central to the story.

This is an important distinction.

Claude is not just answering questions about healthcare processes. It is positioned to participate in those processes today

• Interpreting policy and coverage rules
• Reasoning through multi-step decisions
• Producing structured outputs that move work forward

Enabled with CMS integrations, and core data sources, Claude feel closer to an embedded operational agent than a conversational assistant. It aligns naturally with back-office domains as they exist today where decisions are repeatable, inputs and outputs are structured, and auditability matters as much as reasoning quality.

For organizations focused on revenue cycle operations, utilization management, or payer-facing workflows, this approach will feel immediately familiar. The assumption is that AI will live inside systems, not alongside them.
‍

WHY THIS DISTINCTION MATTERS

Healthcare organizations often struggle when they apply the same AI pattern everywhere.

Patient- and clinician-facing use cases benefit most from explainability, trust, and interaction. Back-office and administrative use cases benefit most from automation, consistency, and throughput.

Seen through this lens, the difference between ChatGPT and Claude is less about raw capability and more about where each fits best in the healthcare value chain.

The most mature healthcare AI strategies in 2026 will almost certainly use both patterns, and in some cases both tools, intentionally. What matters is identifying the initial partner best aligned with your core problem sets.

What the first 15 days of the year have made clear is this: healthcare AI has moved past the question of whether it can be compliant. The real debate now is where should the power of AI be focused.

That is a far more interesting conversation, and a strong signal of where the year’s great debate is headed.
‍

##################################################

‍

Larrian Martin is the Chief Information Officer at GoSB, a specialty revenue cycle management company, and formerly EVP of Data & Insights at Envision Healthcare.

To learn more about how specialization and automation can turn complexity into opportunity, email him at l.martin@go-sb.com.

‍

‍